$2.07
-0.035-1.66%
Last update: Nov 6, 7:25 PM
Niagen Bioscience Inc
NAGENASDAQ
Niagen Bioscience (NAGE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Niagen Bioscience (NAGE) last issued guidance on November 4, 2026 for fiscal year 2026. The company guided revenue in the range of $145.3M - $151.62M for the period.
Compared to prior guidance, Niagen Bioscience raised its revenue forecast from a prior range of $138.98M - $145.3M.
Niagen Bioscience has issued 8 guidance updates between May 7, 2025 and November 4, 2026. During this period, the company raised its outlook 3 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $0.02 | $0.06 | $0.01 |
| Actual | $-0.01 | $0.01 | $0.07 | $0.03 |
| Surprise | +66.7% | -50.0% | +16.7% | +200.0% |
| Revenue | ||||
| Estimate | $32.9M | $31.4M | $30.7M | $31.5M |
| Actual | $27.2M | $29.8M | $31.5M | $33.8M |
| Surprise | -17.3% | -5.02% | +2.43% | +7.55% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.06 | $0.01 | $0.01 | $0.01 |
| Revenue | ||||
| Consensus | $33.1M | $32.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-0.01 | $-0.03 | 66.7 % |
| Q2 | Aug 4, 2026 | $0.01 | $0.02 | -50.0 % |
| Q1 | May 6, 2026 | $0.07 | $0.06 | 16.7 % |
| Q4 | Mar 4, 2026 | $0.03 | $0.01 | 200.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $27.19M | $32.89M | -17.3 % |
| Q2 | Aug 4, 2026 | $29.79M | $31.36M | -5.02 % |
| Q1 | May 6, 2026 | $31.47M | $30.73M | 2.43 % |
| Q4 | Mar 4, 2026 | $33.84M | $31.46M | 7.55 % |
